Specifically, myostatin mRNA and protein levels in sarcopenia patients increased by 2-fold and 1.4-fold, respectively, while Akt phosphorylation efficiency decreased by 30% (Léger et al., 2008). The gene discussed is MSTN; the disease is sarcopenia.